Xi'an International Medical Investment Company Limited

SZSE:000516.SZ

8.66 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991
Revenue 4,617.8732,710.9622,921.1271,606.986990.9532,039.3464,059.5013,930.6823,900.3693,883.3473,565.6743,402.6433,378.132,526.1972,318.7962,041.3171,772.5271,678.2251,626.7071,509.0981,346.931,129.521681.111728.084678.573624.527650.078240.04434.47112.67316.11629.88238.74
Cost of Revenue 4,177.0362,888.9772,877.7141,754.985849.1431,588.5743,252.1393,134.7643,111.3033,081.2782,849.4972,752.2212,774.1882,049.721,955.7951,709.5611,474.241,445.6571,429.7321,324.8231,185.854991.079569.782640.176610.334557.661579.314205.37827.9210.40713.46825.1932.42
Gross Profit 440.838-178.01543.413-147.999141.81450.772807.362795.918789.066802.069716.177650.422603.941476.477363.002331.756298.288232.569196.975184.274161.076138.442111.32987.90868.23966.86670.76534.6666.552.2662.6484.6926.32
Gross Profit Ratio 0.095-0.0660.015-0.0920.1430.2210.1990.2020.2020.2070.2010.1910.1790.1890.1570.1630.1680.1390.1210.1220.120.1230.1630.1210.1010.1070.1090.1440.190.1790.1640.1570.163
Reseach & Development Expenses 9.81215.51312.7969.6937.6841.519000000000000000000000000000
General & Administrative Expenses 627.978144.913143.02486.728100.78856.57848.81939.16629.1319.88431.57334.8128.90716.054126.734120.98697.542109.78794.4679.74267.78660.42749.09826.08713.418.19416.53112.8133.8951.8091.2821.4271.19
Selling & Marketing Expenses 41.42827.26243.31610.02111.29636.36104.024111.348119.527123.984139.224120.442103.89488.82365.14166.19469.40439.20438.74634.03626.79519.99812.81123.11319.81418.4822.24511.0112.4591.4481.2391.6891.559
SG&A 669.406172.175186.3496.749112.08492.938152.843150.513148.657143.867170.798155.252132.801104.877191.876187.18166.946148.992133.206113.77894.58180.42661.90849.233.21436.67438.77623.8246.3543.2572.5213.1152.748
Other Expenses -5.232509.418503.828337.97302.736-3.4863.885.2013.1563.15411.5481.373-2.045-7.136-2.5920.1540.15937.89940.31119.62721.66612.4460.810.3710.7940.8481.881.0491.1960.14-0.228-0.267-0.423
Operating Expenses 741.691697.106702.964444.412422.505344.497510.581492.287484.38448.465469.373438.227381.762301.202218.759209.792183.514162.53145.783123.896101.26382.16763.31251.32835.37638.30442.57226.1816.9773.2833.3024.2314.228
Operating Income -462.022-1,132.602-659.551148.272-280.6953,052.643261.544262.798313.624435.476188.42168.55186.462213.348114.89896.202126.87186.97676.79166.40276.47862.91846.68737.20330.85528.67628.8268.1924.0218.52113.1570.8281.92
Operating Income Ratio -0.1-0.418-0.2260.092-0.2831.4970.0640.0670.080.1120.0530.050.0550.0840.050.0470.0720.0520.0470.0440.0570.0560.0690.0510.0450.0460.0440.0340.1170.6720.8160.0280.05
Total Other Income Expenses Net -5.232-7.703-260.016-140.92-103.8152,942.882-31.358-37.36611.45284.245-86.38-52.437-38.03130.916-32.211-25.73412.257-23.171-16.59-12.939-4.328-7.158-3.0880.106-1.3810.119-1.402-0.3153.939.59413.5630.091-0.596
Income Before Tax -467.254-1,140.305-919.5677.352-384.513,049.157265.423266.265316.139437.849160.423159.758184.148206.19112.03196.23127.0385.87275.85266.73476.81462.24146.21337.1331.56629.10228.7488.7064.368.61912.9190.5561.496
Income Before Tax Ratio -0.101-0.421-0.3150.005-0.3881.4950.0650.0680.0810.1130.0450.0470.0550.0820.0480.0470.0720.0510.0470.0440.0570.0550.0680.0510.0470.0470.0440.0360.1260.680.8020.0190.039
Income Tax Expense 4.69455.034-74.425-27.48528.038805.88368.64264.9775.14487.58838.89948.90156.89453.94532.63525.41438.24732.46129.15228.84828.14221.31310.0865.794.9514.6384.4841.2820.6280.008-0.0160.2610.838
Net Income -368.361-1,195.34-845.14134.837-412.5482,184.294198.391201.592241.025350.283121.536111.046127.253152.2176.75959.16779.24344.51538.2629.97441.71436.38231.15331.94426.8124.46424.2647.4243.7318.61112.4650.2950.658
Net Income Ratio -0.08-0.441-0.2890.022-0.4161.0710.0490.0510.0620.090.0340.0330.0380.060.0330.0290.0450.0270.0240.020.0310.0320.0460.0440.040.0390.0370.0310.1080.6790.7730.010.017
EPS -0.16-0.53-0.380.018-0.211.110.10.10.320.20.0680.0640.0720.0840.10.0840.0560.0320.0220.0170.0240.0210.0180.0190.0170.0150.0150.0050.0020.0050.00800.001
EPS Diluted -0.16-0.53-0.380.018-0.211.110.10.10.320.20.0680.0640.0720.0840.10.0840.0560.0320.0220.0170.0240.0210.0180.0190.0170.0150.0150.0050.0020.0050.00800.001
EBITDA 539.294-242.893-50.986524.283-100.1723,249.81424.748434.494473.232603.231384.751354.449320.803306.063189.004171.755195.777141.721112.18597.161110.63799.12365.18741.27335.06430.62828.1928.485-0.426-1.017-0.6540.4612.093
EBITDA Ratio 0.117-0.09-0.0170.326-0.1011.5940.1050.1110.1210.1550.1080.1040.0950.1210.0820.0840.110.0840.0690.0640.0820.0880.0960.0570.0520.0490.0430.035-0.012-0.08-0.0410.0150.054